CHI3L1 and Alzheimer disease: Most recently, Antonell and colleagues reported increased CSF levels of YKL-40 in preclinical and prodromal AD proposing YKL-40 as a suitable marker for early pathophysiological changes potentially linked to neurodegenerative processes[46].